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A B S T R A C T
Geranium dielsianum (GD) is a perennial plant found in the Andean highlands of Peru. Over
the decades, the decoction of GD has been consumed as a tea protective against diabetes.
Furthermore, GD has traditionally been used as an anti-diabetic, anti-inflammatory, and anti-
diarrheal folk medicine. However, there is little scientific evidence elucidating its effects.
This study aimed to test the effect of the GD extract on the intestinal environment. In male
Sprague–Dawley rats, GD extract increased levels of Bifidobacteria and Lactobacilli and de-
creased levels of Clostridium leptum subgroup and Bacteroides group in the intestine. Furthermore,
3-hydroxyphenylacetic acid was present at high concentrations in the caecal content of GD
extract intake group. Through the above changes in microbiota and microbial metabolites,
faecal bulk and moisture increased and caecal pH and putrefactive products decreased.These
results suggest that GD extract has a potent prebiotic effect.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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1. Introduction
Since the importance of Lactobacilli on good health and lon-
gevity was suggested by Metchnikoff (1907), the relationship
between the intestinal environment and host health has been
extensively studied. It has recently been revealed that the in-
testinal environment affects not only bowel function but also
many biological functions or expressions of disease, such as
immunity (Hooper, Littman, & Macpherson, 2012; Kelly &
Conway, 2005; Tlaskalová-Hogenová et al., 2004), blood pres-
sure (Honour, 1982; Pluznick et al., 2013), lipid metabolism (Hara,
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Haga, Kasai, & Kiriyama, 1998; Klein, Friedrich, Vogelsang, &
Jahreis, 2008), obesity (Bäckhed et al., 2004; Ley, Turnbaugh,
Klein, & Gordon, 2006), mutagenicity (Matsumoto & Benno,
2004), and cancer (Kim, Kim, Lee, & Lee, 2007). The intestinal
environment is considerably influenced by intestinal micro-
bial composition. In the intestine, Lactobacilli and Bifidobacteria
produce a large amount of lactic acid and short-chain fatty acids
(SCFAs), which exert various beneficial effects on their host.
In contrast, intestinal putrefactive bacteria, such as Clostridia,
produce putrefactive products such as ammonia, indole, skatole,
and p-cresol, all of which are substances that have many
harmful effects for host health.
Geranium dielsianum (GD) is a perennial plant that belongs
to the family Geraniaceae. GD flourishes at approximately over
3000 m above sea level in the Andean region of Peru. In Peru,
the decoction of GD is drunk as a tea protective against dia-
betes. Furthermore, GD has traditionally been used as folk
medicine utilised to treat diabetes, inflammation, and chronic
diarrhea. However, scientific verifications about its efficacy have
not been adequately investigated.Therefore, we aimed to elu-
cidate the food functions of GD by testing the efficacy of a
hydrous ethanol GD extract powder (MISKAMISKATM) on the
intestinal environment of rats.
2. Materials and methods
2.1. Materials
Milk casein, corn starch,α-corn starch,mineral AIN-93Gmixture,
and vitamin AIN-93 VX mixture were purchased from CLEA
Japan (Osaka, Japan). Cellulose powder was purchased from
Sigma-Aldrich (St. Louis, MO, USA). Soybean oil was pur-
chased from Nisshin Oillio Group, Ltd. (Tokyo, Japan). All other
chemicals were purchased from Wako Pure Chemical Indus-
tries (Osaka, Japan), unless noted.
2.2. Bacterial strains for microbial quantitation
Bifidobacterium longum JCM 1217T (for Bifidobacteria quantitation),
Bacteroides uniformis JCM 5828T (for Bacteroides–Prevotella–
Porphyromonas (Bacteroides group), total bacteria), Blautia coccoides
JCM 1395T (for Clostridium coccoides group), and genomic DNA
of Ruminococcus albus JCM 14654T (for C. leptum subgroup) were
obtained from Riken Bioresource Center (Ibaragi, Japan). Lac-
tobacillus plantarum NBRC 15891 (for Lactobacilli) and Escherichia
coli NBRC 3301 (for E. coli) were obtained from the National In-
stitute of Technology and Evaluation (Tokyo, Japan). E. coli NBRC
3301 was cultured aerobically in soybean-casein digest (SCD)
broth (Wako Pure Chemical Industries) at 37 °C for 18 h. Other
strains were cultured anaerobically in jar using Anaeropack
Kenki (Mitsubishi Gas Chemicals Co. Ltd.,Tokyo, Japan) in GAM
medium (Nissui Pharmaceutical Co. Ltd.,Tokyo, Japan) at 37 °C
for 18 h. For each culture, the number of bacteria was deter-
mined by plating. E. coli NBRC 3301 was counted after aerobic
incubation at 37 °C for 24 h using SCD agar (Wako Pure Chemi-
cal Industries, Osaka, Japan). B. uniformis JCM 5828T and
B. coccoides JCM 1395T were counted after anaerobic incuba-
tion at 37 °C for 24 h using GAM agar (Nissui Pharmaceutical
Co. Ltd.). B. longum JCM 1217T was counted after anaerobic in-
cubation at 37 °C for 72 h using TOS-Propionate agar medium
(Yakult Pharmaceutical Industry Co. Ltd., Tokyo, Japan).
L. plantarum NBRC 15891 was counted after anaerobic incuba-
tion at 37 °C for 48 h using Lactobacilli MRS agar (Difco
Laboratories, Detroit, MI, USA).
2.3. Test product
MISKAMISKATM (TOWA CORPORATION K.K., Tokyo, Japan) was
produced by extraction from dried whole plant of GD with
hydrous ethanol and evaporation by spray drying. The nutri-
tional composition of the MISKAMISKATM is described in Table 1.
Notably, MISKAMISKATM contains a large amount of polyphe-
nols (Table 1), including catechin (1.327 mg/g), epicatechin
(1.024 mg/g), epigallocatechin (4.833 mg/g), quercetin (1.411 mg/
g) (see Supplementary Table S1). MISKAMISKATM was not found
to present mutagenicity in the Ames test (Table 2).
2.4. Animals and diets
Four-week-old male Sprague–Dawley rats (100–120 g body
weight) were purchased from CLEA Japan (Osaka, Japan) and
housed individually in stainless wire cages in a roomwith con-
trolled temperature (22–24 °C), humidity (50–60%), and lighting
(7:00–19:00). Rats were maintained on non-purified diet (CE-
2; CLEA Japan) for the first 3 days and on a control diet on the
following 10 days.Thereafter, rats were randomly divided into
a control diet group (C group; n = 6) or an experimental diet
group (Miska group; n = 6). The control diet was based on the
AIN-93G diet (Reeves, Rossow, & Lindlauf, 1993), containing 20%
casein, 39.75% corn starch, 13.2% α-corn starch, 10% sucrose,
7% soybean oil, 5% cellulose, 3.5% mineral AIN-93G mixture,
1% vitamin AIN-93 VX mixture, 0.3% L-cysteine, and 0.25%
choline bitartrate. The experimental diet was prepared by
supplementation of the control diet with 2% MISKAMISKATM.
Rats were given ad libitum access to food and water for 9 weeks.
Fresh faeces in the rectum (fresh faeces) and faeces excreted
within 24 h (24-h faeces) were collected in the second and fourth
week of the experiment.At the end of the experiment, rats were
anaesthetised and blood was collected from the abdominal
aorta between 10:00 and 13:00 without fasting.Thereafter, the
Table 1 – Composition of MISKAMISKATM.
Component Composition (%)
Water 4.2
Protein 1.2
Lipid 1.0
Carbohydratea 28.0
Dietary fibreb 2.8
Ash 1.2
Total polyphenolc 61.6
Total 100.0
a Percent of carbohydrate was calculated as follows: %Carbohy-
drate = 100 − (water + protein + lipid + dietary fibre + ash + total
polyphenol).
b Dietary fibre was measured by the Prosky method.
c Total polyphenol was estimated as gallic acid equivalents by Folin–
Ciocalteu method.
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caecum was removed and the caecal content was harvested.
Faeces and caecal content were stored at −45 °C until use.This
experiment was performed following the guidelines of the com-
mittee of Kinki University Faculty of Medicine for care and use
of laboratory animals.
2.5. Extraction of bacterial DNA from faeces and
caecal content
Bacterial DNA in fresh faeces and caecal content were ex-
tracted using the bead-phenol method as previously described
(Matsuki, 2006), with slight modifications. Briefly, 100mg of fresh
faeces or caecal content was suspended in 900 µL of phos-
phate buffered saline with a 5-mm diameter zirconia bead
(Qiagen,Venlo, Netherlands) and shaken with the TissueLyser
(Qiagen, Venlo, Netherlands) (26 s−1, 1 min). Three-hundred
microlitres of homogenate was transferred to a new tube and
375 µL of the extraction buffer {200 mM Tris–HCl, 80 mM
ethylenediaminetetraacetic acid (EDTA) (pH 9.0)}, 75 µL of 10%
SDS, 0.3 g of 1-mm diameter glass beads (TOMY SEIKO Co. Ltd.,
Tokyo, Japan) and 500 µL of buffer-saturated phenol were added.
The mixture was shaken with the TissueLyser (26 s−1, 0.5 min)
and centrifuged (12,000 g, 10 min). DNA was recovered by
phenol–chloroform extraction and isopropanol precipitation.
The DNA pellet was dissolved in 100 µL of TE buffer and then
diluted 100-fold. The DNA template was stored at −45 °C until
use.
2.6. Analysis of intestinal microbiota
Real-time qPCR was performed to analyse the behavior of in-
testinal microbiota using the Applied Biosystems StepOneTM
real-time PCR system (Life Technologies, Carlsbad, CA, USA).
Primers and probes designed based on 16S rRNA gene se-
quences are described in Table 3. Premix Ex Taq (Takara-bio
Inc., Otsu, Japan) was used to quantify the number of total bac-
teria, Lactobacilli, Bifidobacteria,C. leptum subgroup, and C. coccoides
group. SYBR Premix Ex Taq (Takara-bio Inc., Otsu, Japan) was
used to quantify the number of Bacteroides group and E. coli.
When using the Premix Ex Taq, 20 µL of reaction solution con-
tained 1.0 µM (Lactobacilli, Bifidobacteria) or 0.2 µM (C. leptum
subgroup,C. coccoides group, total bacteria) of each primer, 0.2 µM
of each probe, and 2 µL of template DNA.The amplification re-
action consisted of 1 cycle at 95 °C for 20 s and 40 cycles at 95 °C
for 1 s and 60 °C for 20 s.When using the SYBR Premix Ex Taq,
20 µL of reaction solution contained 0.2 µM of each primer,
1 × ROX Reference Dye, and 2 µL of template DNA.The ampli-
fication reaction consisted of 1 cycle at 95 °C for 30 s and 40
cycles at 95 °C for 5 s and 60 °C for 30 s, with melting curve
analysis.
The standard curve of the C. leptum subgroup was gener-
ated using the provided genomic DNA of R. albus JCM 14654T.
Ten-fold dilution series of between 0.0005 and 50 ng/µL (1.0 × 102
to 1.0 × 107 copies/µL) of the genomic DNAwere applied for real-
time PCR. Amounts of the C. leptum subgroup in faeces and
Table 2 – Evaluation of mutagenicity of the MISKAMISKATM in the Ames test, revertants in four strains of Salmonella
typhimurium and one strain of Escherichia coli.
Agent Conc.
(µg/plate)
Revertants/plate (n = 2)
S. typhimurium S. typhimurium E. coli S. typhimurium S. typhimurium
TA100 TA1535 WP2uvrA TA98 TA1537
−S9 mix DMSO 124, 126 16, 18 30, 39 17, 21 13, 20
MISKAMISKATM 39 Not tested Not tested Not tested 15, 13 (0.7) 11, 15 (0.8)
78 Not tested Not tested Not tested 18, 14 (0.8) 15, 15 (0.9)
156 Not tested Not tested Not tested 18, 18 (0.9) 14, 10 (0.7)
313 105, 131 (0.9) 18, 14 (0.9) 33, 22 (0.8) 27, 25 (1.4) 10, 15 (0.8)
625 136, 131 (1.1) 18, 17 (1.0) 26, 34 (0.9) 28, 24 (1.4) 9, 9 (0.5)
1250 131, 129 (1.0) 13, 19 (0.9) 38, 36 (1.1) 21, 13 (0.9) 12, 16 (0.8)
2500 153, 138 (1.2) 23, 26 (1.4) 22, 20 (0.6) Not tested Not tested
5000 139, 161 (1.2) 25, 18 (1.3) 28, 25 (0.8) Not tested Not tested
Positive cont.
AF-2 0.01 634, 617 (5.0) Not tested 144, 156 (4.3) Not tested Not tested
0.1 Not tested Not tested Not tested 554, 517 (28) Not tested
NaN3 0.5 Not tested 376, 407 (23) Not tested Not tested Not tested
ICR-191 1.0 Not tested Not tested Not tested Not tested 1782, 1766 (107)
+S9 mix DMSO 124, 123 8, 14 31, 36 26, 32 18, 22
MISKAMISKATM 313 112, 106 (0.9) 15, 11 (1.2) 29, 29 (0.9) 36, 27 (1.1) 19, 18 (0.9)
625 125, 104 (0.9) 14, 14 (1.3) 42, 36 (1.2) 29, 25 (0.9) 17, 17 (0.9)
1250 108, 116 (0.9) 13, 13 (1.2) 32, 37 (1.0) 34, 35 (1.2) 17, 16 (0.8)
2500 108, 110 (0.9) 11, 13 (1.1) 36, 33 (1.0) 31, 43 (1.3) 14, 16 (0.8)
5000 134, 115 (1.0) 14, 14 (1.3) 25, 20 (0.7) 32, 30 (1.1) 12, 13 (0.6)
Positive cont.
2AA 2.0 Not tested 268, 303 (26) Not tested Not tested Not tested
10 Not tested Not tested 416, 445 (13) Not tested Not tested
B[a]P 5.0 865, 867 (7.0) Not tested Not tested 233, 223 (7.9) 82, 92 (4.4)
Values in brackets (mean index) ≥2 indicates mutagenicity.
DMSO: dimethyl sulfoxide, AF-2: 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide, NaN3: sodium azide, ICR-191: [6-chloro-9-(3-[2-
chloroethylamino]propylamino)-2-methoxyacridine] dihydrochloride, 2AA: 2-aminoanthracene, B[a]P: benzo[a]pyrene.
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caecal content were expressed as copies/wet g. Standard curves
of other groups were generated using the total DNA ex-
tracted from the cultures of standard bacteria, of which the
cell number was previously counted by plating. Ten-fold dilu-
tion series of between ×1,000,000 and ×1 (1.8 × 102–5.4 × 102 to
1.8 × 108–5.4 × 108 CFU/mL) of the total DNA were applied for
real-time PCR. Amounts of each group were expressed as CFU/
wet g.
2.7. Analysis of faecal dry weight and moisture
The dry weight of 24-h faeces was measured after freeze-
drying.An amount of fresh faeces and caecal content were also
freeze-dried and the moisture content was calculated.
2.8. Measurement of pH and organic acids
The pH of the caecal content was measured using a compact
pH meter (B-212; Horiba Ltd., Kyoto, Japan) after a 10-fold di-
lution with distilled water. The concentrations of lactic acid,
acetic acid, propionic acid, and n-butyric acid in caecal content,
and 3-hydroxyphenylacetic acid (3-HPAA) in caecal content and
MISKAMISKATM were measured by using HPLC–UV with aYMC-
Pack FA kit (YMC Co., Ltd., Kyoto, Japan). HPLC analysis was
performed on a Hitachi L-2000 HPLC system (Hitachi High-
Technologies Co., Tokyo, Japan). A YMC-Pack FA column
(6.0 × 250mm;YMC Co., Ltd., Kyoto, Japan) was used in a column
oven at 40 °C. The mobile phase, consisting of acetonitrile/
methanol/water (30:16:54, v/v/v, pH 4.5 adjusted by 0.01 M HCl),
was flowed at a constant flow rate of 1.0 mL/min. The UV de-
tector wavelength was set at 230 nm.
2.9. Measurement of putrefactive products in
caecal content
The concentration of ammonium nitrogen was measured using
an Ammonia Test Wako kit (Wako Pure Chemical Industries).
The concentrations of indole and p-cresol were measured by
using HPLC–UV, as follows: 100 mg of caecal content was placed
in a tube and 600 µL of acetonitrile, 200mg of anhydrous sodium
sulphate, and 400 µL of acetonitrile-saturated hexane were
added; the mixture was then shaken vigorously using a mixer
for 2 min and centrifuged (1500 g, 5 min). Acetonitrile-saturated
hexane (500 µL) was added to 500 µL of the middle acetoni-
trile phase in a new tube and the mixture was shaken
vigorously for 1 min and centrifuged (1500 g, 5 min).The lower
acetonitrile phase was used for analysis after filtration with
a syringe filter. A Mightysil RP-18 GP column (150 × 4.6 mm;
Kanto Chemical Inc., Tokyo, Japan) was used in a column oven
at 40 °C. The mobile phase, consisting of acetonitrile/water
(30:70, v/v), was flowed at a constant flow rate of 1.0 mL/min.
The UV detector wavelength was set at 280 nm.
2.10. Statistical analysis
Statistical analysis was performed using the SYSTAT soft-
ware package, version 11 (SYSTAT Software Inc., Chicago, IL,
USA). Student’s t-test was used to assess the differences of
means. All results are expressed as means ± SEM. Statistical
significance was set at P < 0.05.
Table 3 – Primers and probes for detection of intestinal bacteria.
Primers and probes Sequences (5′–3′) References
Total bacteria
F_eub TCCTACGGGAGGCAGCAGT Nadkarni, Martin, Jacques, and Hunter (2002)
R_eub GGACTACCAGGGTATCTAATCCTGTT
P_eub (FAM)-CGTATTACCGCGGCTGCTGGCAC-(BHQ-1)
Bifidobacteria
F_Bifidobacteria CGCGTCCGGTGTGAAAG Hongwei et al. (2011)
R_Bifidobacteria CTTCCCGATATCTACACATTCCA
P_Bifidobacteria (FAM)-ATTCCACCGTTACACCGGGAA-(BHQ-1)
Lactobacilli
F_Lactobacilli GGCAGCAGTAGGGAATCTTCCA Sprong, Schonewille, and van der Meer (2010)
R_Lactobacilli GCTGCTGGCACGTAGTTAGCC
P_Lactobacilli (FAM)-TGGAGCAACGCCGCGTGAGTGA-(BHQ-1)
C. leptum subgroup
F_C. leptum CCTTCCGTGCCGSAGTTA Furet et al. (2009)
R_C. leptum GAATTAAACCACATACTCCACTGCTT
P_C. leptum (FAM)-CAATAAGTAATCCACCTGGGGAGTACGGCC-(BHQ-1)
C. coccoides group
F_C. coccoides GACGCCGCGTGAAGGA Furet et al. (2009)
R_C. coccoides AGCCCCAGCCTTTCACATC
P_C. coccoides (FAM)-ACGGTACCTGACTAAGAAGCCCCGG-(BHQ-1)
Bacteroides–Prevotella–Porphyromonas (Bacteroides group)
F_Bac GGTGTCGGCTTAAGTGCCAT Rinttilä, Kassinen, Malinen, Krogius, and Palva (2004)
R_Bac CGGAYGTAAGGGCCGTGC
E. coli
F_E. coli CATGCCGCGTGTATGAAGAA Huijsdens et al. (2002)
R_E. coli CGGGTAACGTCAATGAGCAAA
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3. Results
3.1. Growth and food intake
Initial and final body weights and average food intake of the
C group and the Miska group are shown in Table 4. Final body
weight and average food intake of the Miska group were slightly
lower than that in the C group, but there were no significant
differences.
3.2. Intestinal microbiota
There was no significant difference in the number of total bac-
teria between the two groups throughout the experiment
(Fig. 1A). In the Miska group, Bifidobacteria markedly in-
creased from the second week (Fig. 1B) and Lactobacilli were
significantly higher than the C group in the ninth week (Fig. 1C).
In contrast, Bacteroides group were significantly lower in the
second and ninth week (Fig. 1D) and the C. leptum subgroup
significantly decreased from the second week (Fig. 1E). There
was no significant difference in the number of C. coccoides
group and E. coli between the two groups throughout the
experiment (Fig. 1F, G).
3.3. Faeces and caecal content weight and moisture
The dry weight and moisture of faeces and caecal content are
shown in Table 5. In the Miska group, the dry weight of faeces
significantly increased in the second and fourth week. There
was no significant difference between the caecal content of the
two groups.Moisture significantly increased in faeces and caecal
content in the second and fourth week.
3.4. pH and organic acids in caecal content
The pH and the concentrations of organic acids in caecal
content are shown in Table 6. pH was significantly lower in the
Miska group than in the C group. Although the concentra-
tions of lactic acid and SCFAs were not significantly different
between the two groups, a high concentration of 3-HPAA com-
parable to propionic acid was detected only in caecal contents
of the Miska group. 3-HPAA was not detected in MISKAMISKATM
itself (data not shown).
3.5. Putrefactive products in caecal content
The concentrations of putrefactive products in caecal content
are shown in Table 7.Ammonium nitrogen, indole, and p-cresol
all significantly decreased in the Miska group.
4. Discussion
Prebiotics were first defined as “a non-digestible food ingre-
dient that beneficially affects the host by selectively stimulating
the growth and/or activity of one or a limited number of bac-
teria in the colon and thus improves host health” (Gibson &
Roberfroid, 1995). It has since been elucidated that consump-
tion of prebiotics induces characteristic changes in the intestine.
Specifically, prebiotics are selectively consumed by Bifidobacteria
and Lactobacilli, and thus a high volume of lactic acid and SCFAs
are produced in the intestine, resulting in an intestinal pH de-
crease, suppression of intestinal putrefaction with a decrease
of putrefactive bacteria, and an increase in faecal bulk andmois-
ture content.
In this study, supplementation with 2% MISKAMISKATM in
the diet led to clear prebiotic effects in male Sprague–Dawley
rats. In particular, a remarkable increase in Bifidobacteria and
Table 4 – Body weight and average diet intake.
C Miska
Initial body weight (g) 206 ± 4 203 ± 8
Final body weight (g) 636 ± 28 577 ± 44
Diet intake (g/rat/day) 26.2 ± 0.9 23.8 ± 1.5
Data are expressed as means ± SEM, n = 6 in each group.
Table 5 – Dry weight and moisture of faeces and caecal
content.
C Miska
Second week
24-h faeces weight (dry g/rat) 1.58 ± 0.10 2.30 ± 0.26*
Faecal moisture (%) 42.8 ± 2.4 50.4 ± 1.2*
Fourth week
24-h faeces weight (dry g/rat) 1.65 ± 0.05 2.33 ± 0.23*
Faecal moisture (%) 43.4 ± 1.9 54.5 ± 2.7**
Ninth week
Caecal content weight (dry g/rat) 1.10 ± 0.10 1.45 ± 0.16
Caecal content moisture (%) 61.6 ± 1.7 72.3 ± 1.9**
Data are expressed as means ± SEM, n = 6 in each group.
*P < 0.05, and **P < 0.01 represent significant difference from the C
group.
Table 6 – pH and organic acids in caecal content.
C Miska
pH 8.00 ± 0.13 7.28 ± 0.04***
Lactic acid (µmol/wet g) 0.53 ± 0.02 0.83 ± 0.19
Acetic acid (µmol/wet g) 8.18 ± 0.90 7.60 ± 0.33
Propionic acid (µmol/wet g) 4.28 ± 0.21 3.90 ± 0.16
n-Butyric acid (µmol/wet g) 3.05 ± 0.18 2.91 ± 0.24
3-HPAA (µmol/wet g) Not detecteda 4.10 ± 0.42
Data are expressed as means ± SEM, n = 6 in each group.
***P < 0.001 represent significant difference from the C group.
a Detection limit of 3-HPAA was 0.25 µmol/wet g.
Table 7 – Putrefactive products in caecal content.
C Miska
Ammonium nitrogen (µg/wet g) 295 ± 24 213 ± 10**
Indole (µg/wet g) 14.4 ± 1.8 3.3 ± 0.3***
p-Cresol (µg/wet g) 12.3 ± 1.2 4.4 ± 0.5***
Data are expressed as means ± SEM, n = 6 in each group.
**P < 0.01, and ***P < 0.001 represent significant difference from the
C group.
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Fig. 1 – The amount of intestinal bacteria. (A) Total bacteria; (B) Bifidobacteria; (C) Lactobacilli; (D) Bacteroides group; (E)
C. leptum subgroup; (F) C. coccoides group; and (G) E. coli. The C group is expressed with a white bar and the Miska group
with a grey bar. Data are presented as mean ± SEM (each group, n = 6). *P < 0.05, and **P < 0.01 represent a significant
difference from the C group.
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a significant decrease in the C. leptum subgroup were ob-
served from an early stage of the experiment. Furthermore, the
microbial composition was considerably altered at the end of
experiment (Fig. 1A–G). Surprisingly, there were no signifi-
cant differences in the concentrations of lactic acid and SCFAs
between the two groups despite increases in Bifidobacteria and
Lactobacilli and the decrease of pH in caecal content of the Miska
group (Table 6). Instead, 3-HPAA increased remarkably in the
caecal content of the Miska group (Table 6). Other notable
organic acid peaks were not observed in the chromatogram.
A recent study demonstrated that polyphenols present in
the colon are metabolised to simpler phenolic acids by
microbiota. Compared with original polyphenols, these phe-
nolic acids are easily absorbed from the colon, circulate in the
body, and are eventually excreted into urine (Olthof, Hollman,
Buijsman, van Amelsvoort, & Katan, 2003). 3-HPAA has been
reported to be a major urinary metabolite of rutin and its agly-
cone quercetin (Booth, Murray, Jones, & Deeds, 1956; Murray,
Booth, Deeds, & Jones, 1954). Several studies have shown that
3-HPAA is produced by intestinal microbiota (Olthof et al., 2003;
Parker, Trower, & Stevenson, 2013).
In this study,we verified that MISKAMISKATM has a high total
polyphenol content (Table 1) and 3-HPAA was not detected
whenMISKAMISKATM was analysed by HPLC.Therefore, 3-HPAA
in caecal content of the Miska group would be produced by in-
testinal microbiota.We have also analysed that the content of
quercetin (including glycosides and aglycone) was 1.411 mg/g
in MISKAMISKATM (Supplementary Table S1), indicating that
a low amount of quercetin was present in the diet supple-
mented with 2%MISKAMISKATM.Therefore, quercetin and other
unidentified phenolic compounds in MISKAMISKATM may be
sources of 3-HPAA.
Furthermore, a recent study demonstrated that in vitro
supplementation of certain phenolic acids, including 3-HPAA,
advances the proliferation of B. longum more effectively com-
pared with original polyphenols (Parker et al., 2013).Therefore,
our study suggests that 3-HPAA also has potent bifidogenic
effects in vivo and thus increased Bifidobacteria in the Miska
group.
It is unclear which bacteria are involved in the production
of 3-HPAA in the intestine of the Miska group. Although it has
been reported that Clostridium and Eubacterium are the main
genera in the metabolism of many phenolic compounds, such
as flavonols, flavan-3-ols, flavones, and isoflavones (Selma,
Espin, & Tomas-Barberan, 2009), the complete mechanism of
polyphenol metabolism by intestinal microbiota remains
unclear.
5. Conclusions
The diet supplemented with 2% MISKAMISKATM led to a re-
markable increase in 3-HPAA concentration and microbial
change characterised by a remarkable increase in Bifidobacteria.
As a result, caecal pH fell to a lower range, putrefactive
products were decreased, and faecal bulk and moisture
were increased. These results strongly suggest that the
MISKAMISKATM may have a beneficial function to promote good
health through its potent prebiotic effects. To clarify the
underlying mechanisms, detailed polyphenol analyses in
MISKAMISKATM and identification of the intestinal bacteria,
which play a key role in the production of 3-HPAA upon
MISKAMISKATM intake, are required.
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